Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial

DSpace Repository

Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial

Author: Paschka, Peter; Schlenk, Richard F.; Weber, Daniela; Benner, Axel; Bullinger, Lars; Heuser, Michael; Gaidzik, Verena I.; Thol, Felicitas; Agrawal, Mridul; Teleanu, Veronica; Luebbert, Michael; Fiedler, Walter; Radsak, Markus; Krauter, Juergen; Horst, Heinz-A.; Greil, Richard; Mayer, Karin; Kuendgen, Andrea; Martens, Uwe; Heil, Gerhard; Salih, Helmut R.; Hertenstein, Bernd; Schwaenen, Carsten; Wulf, Gerald; Lange, Elisabeth; Pfreundschuh, Michael; Ringhoffer, Mark; Girschikofsky, Michael; Heinicke, Thomas; Kraemer, Doris; Goehring, Gudrun; Ganser, Arnold; Doehner, Konstanze; Doehner, Hartmut
Tübinger Autor(en):
Salih, Helmut Rainer
Published in: Leukemia (2018), Bd. 32, H. 7, S. 1621-1630
Verlagsangabe: Nature Publishing Group
Language: English
Full text: http://dx.doi.org/10.1038/s41375-018-0129-6
ISSN: 1476-5551
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)